feed,title,long_url,short_url
Benzinga,Revive Therapeutics Data Access Plan Approved By The FDA; Partial Unblinded Data In Company Hands,https://benzinga.com/markets/penny-stocks/22/06/27905350/revive-therapeutics-data-access-plan-approved-by-the-fda-partial-unblinded-data-in-company-h,https://bit.ly/3OywCOn
